BioCardia
BioCardia, Inc. develops cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases.
$4.4M ·
Source: fundraisingfox.com
Funding history ↓Signals
X account@biocardia_inc · created Feb 3, 2022 (4 years old) · 97 followers
Website registeredMar 24, 1999 (27 years old)
Funding rounds
- Round · $4.4MSource: fundraisingfox.com
- X account created
- Website created
Companies like BioCardia
IImmumem TherapeuticsPre Seed · May 2026
SSyntax$14.4M · Jun 2026RResolution TherapeuticsSeries B+ · Oct 2024
CCelea Therapeutics$180M Series A · Jul 2026
AAirNexis Therapeutics$200M Series A · Jan 2026
AArnatar Therapeutics$50M Series A · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/biocardia (get a free API key).